Canada Pension Plan Investment Board’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Canada Pension Plan Investment Board's PTCT Position: Q2 2026 in Review
Canada Pension Plan Investment Board reduced its PTC Therapeutics (PTCT) stake by 89% in Q2 2026, selling an estimated $3.26M and leaving 5,400 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.
Canada Pension Plan Investment Board first reported a position in PTCT in Q3 2015 and has held it in 17 quarters since. The position peaked at $13.6M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Canada Pension Plan Investment Board held 5,400 shares of PTC Therapeutics worth $440K as of Q2 2026.
- Canada Pension Plan Investment Board sold 45,106 PTC Therapeutics shares in Q2 2026, an estimated $3.26M.
- PTC Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1316 holding.
- Canada Pension Plan Investment Board first reported a position in PTC Therapeutics in Q3 2015 and has held it in 17 quarters since.
- Canada Pension Plan Investment Board's PTC Therapeutics position peaked at $13.6M in Q4 2020.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.